|

all-trans retinoic acid Clinical Trials

4 actively recruiting trials across 2 locations

Also known as: ATRA, Tretinoin, VESANOID, retinoic acid, tretinoin, vitamin A acid

Other2 trials

Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer
Phase 1/2
Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia
Phase 2

Columbus, Ohio1 trial

Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma

Ohio State University Comprehensive Cancer Center

Phase 2

Philadelphia, Pennsylvania1 trial

All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma

University of Pennsylvania

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.